how to get a doctor to prescribe glp 1 Why I GLP-1 Agonists as an Integrative Medicine Here's What Responsible Prescribing Looks

Biochem Biophys Res Commun 2017;490:5529

Patients should understand that expected weight loss varies by medication (approximately 5-10% with liraglutide, 10-15% with semaglutide, and potentially higher with tirzepatide), though responses in post-bariatric patients may differ from those in primary obesity treatment

Using expired semaglutide is most likely not a good idea

At the same time, obesity is showing up more often across the world, and there is also more public awareness about obesity related health complications which, is pushing people toward better solutions

Keywords: glucagon-like peptide-1 receptor agonists (GLP-1RAs), hormonal regulation, insulin resistance (IR), metabolic health, polycystic ovary syndrome (PCOS), reproductive health Introduction Polycystic ovary syndrome (PCOS) is a widespread endocrine and metabolic ailment occurring in about 6%20% of females of childbearing age

Obesity is also a leading driver of gastrointestinal (GI) and hepatobiliary cancers, from colorectal cancer to hepatocellular carcinoma, making any therapy that modifies obesity-related cancer risk directly relevant to gastroenterology practice